- Bristol Myers plans UK launch of schizophrenia drug Cobenfy, matching US price Reuters
- UK under pressure as BMS sets US-level price for schizophrenia drug Financial Times
- Bristol Myers plans UK launch of schizophrenia drug in 2026 The Mighty 790 KFGO
- Bristol Myers Squibb Aligns Schizophrenia Drug Pricing in UK and US MSN